Melinta Therapeutics bid procedures and cash use hearings adjourned

By Caroline Salls

Pittsburgh, Jan. 30 – Melinta Therapeutics, Inc.’s Jan. 31 bid procedures and cash collateral use hearings have been adjourned to a date to be determined during the week of Feb. 3, according to a notice filed Thursday with the U.S. Bankruptcy Court for the District of Delaware.

No reason was given for the cancellation of Friday’s hearing or the adjournment.

Melinta is an antibiotics company based in New Haven, Conn. The company filed bankruptcy on Dec. 27 under Chapter 11 case number 19-12748.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.